Editas Medicine, Inc.
EDIT· Nasdaq
EDITEditas Medicine, Inc.
Filed Nov 8, 2017 · 10-Q · 39 days after period end · 0001558370-17-008429
| Metric | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|
| Revenue | $6.28M | — | — |
| Net Income | -$26.60M | -$21.02M | -$7.41M |
| EPS Diluted | -$0.64 | -$0.59 | -$2.57 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Editas Medicine, Inc. · CIK 1650664 · Engraved from SEC EDGAR
ended Sep 30, 2017 · filed Nov 8, 2017 · 39 d after period end
